On the other hand, this latter limitation can represent a specific strength of our study in that it shows that lower adiponectin levels are associated with NAFLD and significant fibrosis in the absence of major changes in glycemia. This evidence concerns the gene ADIPOQ and metabolic dysfunction-associated steatotic liver disease.